Learn More
Log In
Sign Up
21 C.F.R. Part 524 – Ophthalmic and Topical Dosage Form New Animal Drugs | Midpage
Collections
Code of Federal Regulations
Title 21
Chapter I
Subchapter E
Part 524
21 C.F.R. Part 524
Ophthalmic and Topical Dosage Form New Animal Drugs
524.86
Amitraz.
524.154
Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
524.155
Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
524.230
Buprenorphine.
524.390
Chloramphenicol ophthalmic ointment.
524.402
Chlorhexidine.
524.450
Clotrimazole.
524.463
Copper naphthenate.
524.575
Cyclosporine ophthalmic ointment.
524.590
Diclofenac.
524.660
Dimethyl sulfoxide.
524.770
Doramectin.
524.775
Emodepside and praziquantel.
524.802
Enrofloxacin and silver sulfadiazine otic emulsion.
524.814
Eprinomectin.
524.815
Eprinomectin and praziquantel.
524.838
Esafoxolaner, eprinomectin, and praziquantel.
524.900
Famphur.
524.920
Fenthion.
524.955
Florfenicol, terbinafine, and betamethasone acetate otic gel.
524.957
Florfenicol, terbinafine, and mometasone otic solution.
524.960
Flumethasone, neomycin, and polymyxin B ophthalmic solution.
524.970
Flunixin.
ECFR69891ec6e22fe4b
Fluocinolone Topical and Otic Dosage Forms